Magen-Rimon Ramit, Mamet David, Assaf Meis, Tal-Leshinsky Zohar, Libman Oxana, Waterman Matti, Bar-Yoseph Haggai
Pediatric Gastroenterology Institute, Rambam Health Care Campus, Haifa 3109601, Israel.
The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
Nutrients. 2025 Sep 12;17(18):2945. doi: 10.3390/nu17182945.
Exclusive enteral nutrition (EEN) effectively induces remission in pediatric Crohn's disease (CD), but reasons for its limited use in adults remain unclear. This study aimed to identify and compare patients' and physicians' perspectives on barriers to EEN use, in order to inform strategies to enhance its utilization. An online questionnaire was distributed to adult CD patients and gastroenterologists, collecting data on demographics, disease characteristics, previous EEN exposure, and attitudes toward EEN and potential barriers (Likert scale 1-5). Comparative analysis and logistic regression identified factors associated with reluctance toward EEN. A total of 315 CD patients (mean age 36.7) and 42 physicians completed the survey. Previous EEN use was reported by 40%, while 20.3% of the entire cohort were reluctant to use it. The only factor that predicted reluctance was current use of advanced therapy (OR 2.06 [95%CI 1.05-4.35]). Among physicians, 71% had prescribed EEN, and 81% were willing to do so. Key barriers were lack of food variety (65% Likert score > 3) and reduced social interaction (59%) among patients and social interaction (67.3%) and taste concerns (54.7%) among physicians. Patients rated hunger sensation and lack of food variety concerns as more significant barriers than physicians. Patients identified direct communication with staff (68.6% Likert score > 3) and full cost coverage (65%) as facilitators for adherence. Notably, 87% wanted more information from their doctors. Most adult CD patients and physicians are open to discuss EEN. Removing barriers related to palatability and diversity of enteral nutrition, as well as shortening of EEN duration, may enhance acceptance of and adherence to EEN.
全肠内营养(EEN)可有效诱导小儿克罗恩病(CD)缓解,但在成人中使用受限的原因尚不清楚。本研究旨在确定并比较患者和医生对EEN使用障碍的看法,以便为提高其利用率提供策略依据。向成年CD患者和胃肠病学家发放了一份在线问卷,收集有关人口统计学、疾病特征、既往EEN接触情况以及对EEN的态度和潜在障碍的数据(李克特量表1 - 5)。比较分析和逻辑回归确定了与不愿使用EEN相关的因素。共有315名CD患者(平均年龄36.7岁)和42名医生完成了调查。40%的患者报告曾使用过EEN,而整个队列中有20.3%的患者不愿使用。唯一预测不愿使用的因素是当前正在使用高级疗法(比值比2.06 [95%置信区间1.05 - 4.35])。在医生中,71%曾开具过EEN处方,81%愿意这样做。主要障碍包括患者缺乏食物多样性(65%李克特评分>3)和社交互动减少(59%),以及医生方面的社交互动(67.3%)和口味担忧(54.7%)。患者将饥饿感和缺乏食物多样性担忧视为比医生更重要的障碍。患者认为与工作人员直接沟通(68.6%李克特评分>3)和全额费用覆盖(65%)是坚持使用EEN的促进因素。值得注意的是,87%的患者希望从医生那里获得更多信息。大多数成年CD患者和医生愿意讨论EEN。消除与肠内营养的适口性和多样性相关的障碍,以及缩短EEN疗程,可能会提高对EEN的接受度和依从性。